Although the sample size of TFE3-RCC (n = 15) in The Cancer Genome Atlas (TCGA) is small, there is a subtle trend indicating that lower ARID2 expression may be associated with poorer prognosis (Supplemental Figure S2). Here, TFE3 is linked to renal cell carcinoma.